University of Aberdeen

AURA - Aberdeen University Research Archive

View Item 
  •   AURA Home
  • 5 - All research
  • All research
  • View Item
  •   AURA Home
  • 5 - All research
  • All research
  • View Item
  •   AURA Home
  • 5 - All research
  • All research
  • View Item
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease : Analyses Conducted for Canada, France, Italy, and Portugal

      View/Open
      LANTERN_multi_country_revised_MS_08032016_Copy.docx (200.2Kb)
      Publication date
      10/2016
      Author
      Maleki-Yazdi, M. Reza
      Molimard, Mathieu
      Keininger, Dorothy L
      Gruenberger, Jean-Bernard
      Carrasco, Joao
      Pitotti, Claudia
      Sauvage, Elsa
      Chehab, Sara
      Price, David Brendan
      Keywords
      R Medicine
      Metadata
      Show full item record
      Citation
      Maleki-Yazdi , M R , Molimard , M , Keininger , D L , Gruenberger , J-B , Carrasco , J , Pitotti , C , Sauvage , E , Chehab , S & Price , D B 2016 , ' Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease : Analyses Conducted for Canada, France, Italy, and Portugal ' , Applied Health Economics and Health Policy , vol. 14 , no. 5 , pp. 579-594 . https://doi.org/10.1007/s40258-016-0256-z
      Publication
      Applied Health Economics and Health Policy
      Status
      Peer reviewed
      DOI
      https://doi.org/https://doi.org/10.1007/s40258-016-0256-z
      Type
      Journal article
      Description
      Acknowledgments The authors would like to thank Purnima Pathak (Novartis) for providing writing assistance in the development of this manuscript. The authors would also like to thank Colin Burke and Ronan Mahon (Health Economic Modelers; Novartis) for their modeling support. Medical writing support was funded by Novartis Pharma AG (Basel, Switzerland).
      Collections
      • All research
      • Applied Health Sciences research
      • University Office research
      URI
      http://hdl.handle.net/2164/9140

      Browse

      All of AURACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
      Top of Page
      • AURA Home
      • Accessibility
      • PURE
      • Digital Resources
      • Library, Special Collections & Museums
      • Take-Down Notice
      • Send Feedback
      • Contact Us
         
       
      Library, Special Collections and Museums logo
      The Sir Duncan Rice Library
      University of Aberdeen
      Bedford Road
      Aberdeen
      AB24 3AA

      Tel: +44 (0)1224 273330
      Email: library@abdn.ac.uk
       
         

      Share and keep up to date

      FacebookTwitterWordpress

      • AURA Home
      • Accessibility
      • PURE
      • Digital Resources
      • Library, Special Collections & Museums
      • Take-Down Notice
      • Send Feedback
      • Contact Us